Culmination Bio Raises $10M From Amgen Ventures and Merck Gl

Culmination Bio, a company building the largest disease-agnostic patient data intelligence platform, today announced a $10 million investment from Merck Global Health Innovation Fund (Merck GHI) and Amgen Ventures. As a spinoff from Intermountain Health, Culmination Bio maintains exclusive rights to a physical library and cloud-based data lake covering over 40 years of de-identified patient electronic health records and biospecimen data. As the most extensive data lake of its kind, it...

Related Keywords

Utah , United States , David Reese , Melissa Mowery , Davidm Rubin , Merck Global Health Innovation Fund , Intermountain Health , Culmination Bio Raises , From Amgen Ventures , Bring Longitudinal Health Data , Culmination Bio , Intelligence Platform , Managing Director , Merck Global Health Innovation , Press Release Image , Amgen , Merck , Data , Culmination , Ohio , Company , Building , Largest , Isease Agnostic , Patient , Intelligence , Platform , 0 , Billion , Investment , Lobal , Health , Innovation , Fund , Hi , Dentures , Spinoff , Intermountain , Aintains , Exclusive , Tights , Physical , Library , Cloud Based , Lake , Covering , Tears , Are Identified , Lectronic , Records , Iospecimen , Xtensive , Wind , Ebwire , Press Release , Ews Release ,